C.R.S. Section 18-18-204
Schedule II


(1)

A substance shall be added to schedule II by the general assembly when:

(a)

The substance has high potential for abuse;

(b)

The substance has currently accepted medical use in treatment in the United States, or currently accepted medical use with severe restrictions; and

(c)

The abuse of the substance may lead to severe psychological or physical dependence.

(2)

Unless specifically excepted by Colorado or federal law or Colorado or federal regulation or more specifically included in another schedule, the following controlled substances are listed in schedule II:

(a)

Any of the following substances, however manufactured:

(I)

Opium and opium derivative, and any salt, compound, derivative, or preparation of opium or opium derivative, excluding apomorphine, dextrorphan, nalbuphine, butorphanol, nalmefene, naloxone, and naltrexone, but including:

(A)

Raw opium;

(B)

Opium extracts;

(C)

Opium fluid;

(D)

Powdered opium;

(E)

Granulated opium;

(F)

Tincture of opium;

(G)

Codeine;

(H)

Ethylmorphine;

(I)

Etorphine hydrochloride;

(J)

Hydrocodone;

(K)

Hydromorphone;

(L)

Metopon;

(M)

Morphine;

(N)

Oxycodone;

(O)

Oxymorphone;

(P)

Thebaine.

(II)

Any salt, compound, derivative, or preparation that is chemically equivalent or identical with any of the substances listed in subparagraph (I) of this paragraph (a), but not isoquinoline alkaloids of opium;

(III)

Opium poppy and poppy straw;

(IV)

Coca leaves and any salt, compound, derivative, or preparation of coca leaves, including cocaine and ecgonine and their salts, isomers, derivatives, and salts of isomers and derivatives, and any salt, compound, derivative, or preparation that is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine;

(V)

Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy).

(b)

Any of the following synthetic opiates, including any isomers, esters, ethers, salts, and salts of isomers, esters, and ethers of them that are theoretically possible within the specific chemical designation:

(I)

Alfentanil;

(II)

Alphaprodine;

(III)

Anileridine;

(IV)

Benzitramide;

(V)

Carfentanil;

(VI)

Dihydrocodeine;

(VII)

Diphenoxylate;

(VIII)

Fentanyl;

(IX)

Isomethadone;

(IX.5)

Levo-alphacetylmethadol;

(X)

Levomethorphan;

(XI)

Levorphanol;

(XII)

Metazocine;

(XIII)

Methadone;

(XIV)

Methadone - Intermediate, 4-cyano-2- dimethylamino-4, 4-diphenyl butane;

(XV)

Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;

(XVI)

Pethidine (meperidine);

(XVII)

Pethidine - Intermediate-A, 4-cyano-1- methyl-4-phenylpiperidine;

(XVIII)

Pethidine - Intermediate-B, ethyl-4- phenylpiperidine-4-carboxylate;

(XIX)

Pethidine - Intermediate-C, 1-methyl- 4-phenylpiperidine-4-carboxylic acid;

(XX)

Phenazocine;

(XXI)

Piminodine;

(XXII)

Propoxyphene (non-dosage forms);

(XXIII)

Racemethorphan;

(XXIV)

Racemorphan;

(XXV)

Sufentanil.

(c)

Any material, compound, mixture, or preparation containing any quantity of the following substances, their salts, isomers, or salts of isomers, having a stimulant effect on the central nervous system:

(I)

Amphetamine;

(II)

Methamphetamine;

(III)

Phenmetrazine;

(IV)

Methylphenidate.

(d)

Any material, compound, mixture, or preparation containing any quantity of the following substances having a depressant effect on the central nervous system, including any salts, isomers, and salts of isomers of them that are theoretically possible within the specific chemical designation:

(I)

Amobarbital;

(II)

Pentobarbital;

(III)

Phencyclidine;

(IV)

Secobarbital;

(V)

Glutethimide.

(e)

Intentionally left blank —Ed.

(I)

Repealed.

(II)

Nabilone [Another name for nabilone: (+) trans-3-(1,1-demethylheptyl)-6,6a,7,8,10, 10a-hexahydro- 1-hydroxy-6,6-dimethyl-9Hdibenzo [b,d] pyran-9-one].

(f)

Any material, compound, mixture, or preparation containing any quantity of the following substances:

(I)

Immediate precursor to amphetamine and methamphetamine: phenylacetone (Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.), ephedrine, alpha-phenylacetoacetonitrile, phenylacetic acid, and 1-phenyl-2-nitropropene;

(II)

Immediate precursors to phencyclidine:

(A)

1-phenylcyclohexylamine;

(B)

1-piperidinocyclohexanecarbonitrile (PCC);

(C)

Piperdine;

(D)

Morpholine;

(E)

Pyrrolidine;

(III)

Remifentanil hydrochloride.

(g)

Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which is a controlled substance analog, as defined in section 18-18-102 (6), the chemical structure of which is substantially similar to the chemical structure of a controlled substance in schedule II of this part 2 or that was specifically designed to produce an effect substantially similar to or greater than the effect of a controlled substance in schedule II of this part 2, all or part of which is intended for human consumption, shall be treated for the purposes of this article as a controlled substance in schedule II of this part 2.

Source: Section 18-18-204 — Schedule II, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-18.­pdf (accessed Oct. 20, 2023).

18‑18‑101
Short title
18‑18‑102
Definitions
18‑18‑103
Special definition - board
18‑18‑201
Authority to control
18‑18‑202
Nomenclature
18‑18‑203
Schedule I
18‑18‑204
Schedule II
18‑18‑205
Schedule III
18‑18‑206
Schedule IV - repeal
18‑18‑207
Schedule V
18‑18‑301
Rules
18‑18‑302
Registration requirements - definitions
18‑18‑303
Registration
18‑18‑304
Suspension or revocation of registration
18‑18‑305
Order to show cause
18‑18‑306
Records of registrants
18‑18‑307
Order forms
18‑18‑308
Prescriptions
18‑18‑309
Diversion prevention and control
18‑18‑401
Legislative declaration
18‑18‑402
Definitions - terms used
18‑18‑403
Additional definition
18‑18‑403.5
Unlawful possession of a controlled substance - notice to revisor of statutes - repeal
18‑18‑404
Unlawful use of a controlled substance
18‑18‑405
Unlawful distribution, manufacturing, dispensing, or sale
18‑18‑406
Offenses relating to marijuana and marijuana concentrate - definitions
18‑18‑406.1
Unlawful use or possession of synthetic cannabinoids or salvia divinorum
18‑18‑406.2
Unlawful distribution, manufacturing, dispensing, sale, or cultivation of synthetic cannabinoids or salvia divinorum
18‑18‑406.3
Medical use of marijuana by persons diagnosed with debilitating medical conditions - unlawful acts - penalty - medical marijuana program cash fund
18‑18‑406.4
Unlawful advertising of marijuana - exception
18‑18‑406.5
Unlawful use of marijuana in a detention facility
18‑18‑406.6
Extraction of marijuana concentrate - definitions
18‑18‑406.9
Unlawful distribution or purchase of dextromethorphan - penalty - preemption - definitions
18‑18‑407
Special offender - definitions
18‑18‑409
Reduction or suspension of sentence for providing substantial assistance
18‑18‑410
Declaration of class 1 public nuisance
18‑18‑411
Keeping, maintaining, controlling, renting, or making available property for unlawful distribution or manufacture of controlled substances
18‑18‑412
Abusing toxic vapors - prohibited
18‑18‑412.5
Unlawful possession of materials to make methamphetamine and amphetamine - penalty
18‑18‑412.7
Sale or distribution of materials to manufacture controlled substances
18‑18‑412.8
Retail sale of methamphetamine precursor drugs - unlawful acts - penalty
18‑18‑413
Authorized possession of controlled substances
18‑18‑414
Unlawful acts - licenses - penalties
18‑18‑415
Fraud and deceit
18‑18‑416
Controlled substances - inducing consumption by fraudulent means
18‑18‑417
Notice of conviction
18‑18‑418
Exemptions
18‑18‑419
Imitation and counterfeit controlled substances act
18‑18‑420
Imitation controlled substances - definitions
18‑18‑421
Imitation controlled substances - determination - considerations
18‑18‑422
Imitation controlled substances - violations - penalties
18‑18‑423
Counterfeit substances prohibited - penalty
18‑18‑424
Imitation controlled substances - exceptions
18‑18‑425
Drug paraphernalia - legislative declaration
18‑18‑426
Drug paraphernalia - definitions
18‑18‑427
Drug paraphernalia - determination - considerations
18‑18‑428
Possession of drug paraphernalia - penalty
18‑18‑429
Manufacture, sale, or delivery of drug paraphernalia - penalty
18‑18‑430
Advertisement of drug paraphernalia - penalty
18‑18‑430.5
Drug paraphernalia - exemption
18‑18‑431
Defenses
18‑18‑432
Drug offender public service and rehabilitation program - definitions
18‑18‑433
Constitutional provisions
18‑18‑434
Offenses relating to natural medicine and natural medicine product - definitions
18‑18‑501
Administrative inspections and warrants
18‑18‑502
Injunctions
18‑18‑503
Cooperative arrangements and confidentiality
18‑18‑504
Pleadings - presumptions - liabilities
18‑18‑505
Judicial review
18‑18‑506
Education and research
18‑18‑601
Pending proceedings - applicability
18‑18‑602
Continuation of rules - application to existing relationships
18‑18‑603
Statutes of limitations
18‑18‑604
Uniformity of interpretation
18‑18‑605
Severability
18‑18‑606
Drug case data collection
18‑18‑607
Safe stations - disposal of controlled substances - medical evaluation - definition
Green check means up to date. Up to date

Current through Fall 2024

§ 18-18-204’s source at colorado​.gov